4Roberts J Ⅱ, Anthony LB. In: Wilson JD, et al (eds). Williams Textbook of Endocrinology. 9th ed. Philadlphia: W, B. Saunders Co,1998,362-363.
5Repaske DR, Phillips JA 3rd, Kirby LT. Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endecrinol Metab, 1990,70:752-757.
6Christensen JH, Siggaard C, Corydon TJ. Impaired trafficking of mutated AVP prohormone in cells expressing tare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf), 2004,60:125-136.
7Gabreels BA, Swaab DF, de kleijn DP, et al. Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients : indications for a processing defect. J Clin Endecrinol Metab, 1998,83:591-599.
8Rossi NF. Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial Explants. Am J Physiol Endocrinol Metab, 2004,286 : ES35-E541.
9Ishizaki S, Murase T, Sugimura Y. Role of ghrelin in the regulation of vasopressin release in conscious rats. Endocrinology, 2002,143:1589-1593.
10Kuwahara S, Arima H, Banno R. Regulation of vasopressin gene expression by cAMP and glucocorticoids in parvocellular neurons of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neurosci, 2003,23 : 10231-10237.
